HIV-HBV and HIV-HCV coinfection and liver cancer development.

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Hepatitis B Virus 100%
• Liver Cancer 100%
• Mixed Infection 100%
• Infection 37%
• Liver Cirrhosis 25%
• Liver Carcinogenesis 25%
• Liver Disease 25%
• Virus Hepatitis 25%
• Hepatotoxicity 12%
• Liver Injury 12%
• Human Immunodeficiency Virus Infection 12%

Keyphrases

• HBV-HCV Coinfection 100%
• HIV-HCV Coinfection 100%
• Chronic HCV Infection 66%
• Chronic Viral Hepatitis 66%
• In Vivo Model Systems 33%
• HCV Infection 33%
• Co-infected Patients 33%
• Art Therapy 33%
• Multiple Virus 33%